Deciphera Pharmaceuticals, Inc(NASDAQ:DCPH) 
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-12-18
P
O 15.85
H 16.00
L 15.56
C 15.86
V 458,894
10EMA 15.86
20EMA 15.86
60EMA 15.86
120EMA 15.86
250EMA 15.86